Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
AT&T, Group 1 Automotive, Mattel, Seagate And Other Big Stocks Moving Higher On Wednesday
Compass a New Outperform at RBC on Optimism for Psychedelic-based Therapies
Alkermes Q2 2024 Earnings Preview
Notable Earnings Before Wednesday's Open
RBC Capital Initiates Coverage On Compass Pathways With Outperform Rating, Announces Price Target of $23
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
Needham Maintains Buy on Intra-Cellular Therapies, Raises Price Target to $100
6 Analysts Assess Alkermes: What You Need To Know
Earlier, Relmada Therapeutics Announced Publication Of Results From The Phase 3 Reliance I Study of REL-1017 In The Journal Of Clinical Psychiatry
China's Bilibili And Ollie's Bargain Outlet Were Among 10 Mid Cap Stocks With Biggest Gains In The Last Week (June 16-June 22, 2024): Are They In Your Portfolio?
Compass Pathways Analyst Ratings
ATAI Life Sciences Analyst Ratings
Patterson Companies, Silk Road Medical, Micron, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Tuesday
Market-Moving News for June 18th
Intra-Cellular Gains After Late-stage Win for Mood Disorder Therapy
The Analyst Landscape: 7 Takes On Alkermes
Alkermes Analyst Ratings
Intra-Cellular Therapies Analyst Ratings
NRx Pharmaceuticals Publishes Shareholder Update Letter; Update Highlights Potential Implications Of The Company's Recent Activities At The Annual Meeting Of The American Society Of Clinical Psychopharmacology